A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model.
Eur J Haematol
; 96(2): 198-208, 2016 Feb.
Article
in En
| MEDLINE
| ID: mdl-25892333
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thalidomide
/
Antineoplastic Combined Chemotherapy Protocols
/
Cost-Benefit Analysis
/
Bortezomib
/
Multiple Myeloma
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
En
Journal:
Eur J Haematol
Journal subject:
HEMATOLOGIA
Year:
2016
Type:
Article
Affiliation country:
Netherlands